Clinical Trials Logo

Clinical Trial Summary

It is being revealed that the more severe the damage of the endothelial glycocalyx (EG) layer, the more likely it is that the prognosis of the patients is poor. For that reason, research is being actively conducted on methods for reducing damage and promoting recovery of the EG layer.The natural regeneration process of the EG layer is up to 7 days. Considering the fact that it is quiet slow, reducing the damage of EG layer is considered to be very important for improving the prognosis of patients undergoing surgery, but there is no clinically proven method. One of the ways receiving attention to reduce damage of EG layer is to stabilize the layer through fluid therapy with albumin. The purpose of this study is to compare the protective effect of the EG layer according to the type of fluid (balanced crystalloid solution vs. 5% albumin) during surgery in patients undergoing off-pump coronary artery bypass surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Coronary Artery Occlusive Disease(CAOD)

NCT number NCT03699462
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase Phase 4
Start date November 13, 2018
Completion date October 17, 2020